Pharmacist coaching boosts diabetes control in nigerian hospital study
NCT ID NCT07507305
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether extra support from a pharmacist can help people with type 2 diabetes manage their blood sugar better. 122 participants were split into two groups: one got usual care, the other got usual care plus regular pharmacist sessions covering medication use, healthy habits, and blood sugar monitoring. The goal was to see if pharmacist support leads to better blood sugar levels and overall health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pharmaceutical care (pharmacist-led education, medication review, and self-monitoring training)
- What this could lead to
- If it works, this could show that adding pharmacist support to standard diabetes care improves blood sugar control and reduces complications.
- What could go wrong
- This is a small, single-site study with 122 participants, so results may not apply widely. The intervention is behavioral, so benefits may vary by patient adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
122 people
The number who actually took part.
- Started
-
Feb 2024
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1\. Patients diagnosed with type 2 diabetes mellitus, confirmed by clinical documentation. 2\. Patients who have received oral antidiabetic and/ or insulin therapy within the 30 days prior to recruitment. 3\. Patients who have demonstrated consistent attendance at clinic visits for three consecutive months before recruitment. 4\. Patients who are proficient in either English or Hausa 5. Patients who provided written consent to participate in the study in accordance with ethical standards. 6\. Patients aged 18 years or older. Exclusion Criteria: * 1\. Critically ill patients 2. Pregnant women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yobe State University Teaching Hospital
Maiduguri, Borno State, Nigeria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness and yoga rewire diabetes habits?
- Can a vegan diet delivered online help people with type 2 diabetes?
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Gut microbes in pregnancy and infancy: a window into lifelong health?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Chatbot coach takes aim at diabetes risk after pregnancy